References
- Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, et al. Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity. Cell. 1995; 80: 279–84
- Cutress RI, Townsend PA, Brimmell M, Bateman AC, Hague A, Packham G. BAG-1 expression and function in human cancer. Br J Cancer. 2002; 87: 834–9
- Kiang JG, Tsokos GC. Heat shock protein 70 kDa: Molecular biology, biochemistry, and physiology. Pharmacol Ther. 1998; 80: 183–201
- Troppmair J, Rapp UR. Raf and the road to cell survival: A tale of bad spells, ring bearers and detours. Biochem Pharmacol. 2003; 66: 1341–5
- Bardelli A, Longati P, Albero D, Goruppi S, Schneider C, Ponzetto C, et al. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J. 1996; 15: 6205–12
- Hung WJ, Roberson RS, Taft J, Wu DY. Human BAG-1 proteins bind to the cellular stress response protein GADD34 and interfere with GADD34 functions. Mol Cell Biol. 2003; 23: 3477–86
- Lin J, Hutchinson L, Gaston SM, Raab G, Freeman MR. BAG-1 is a novel cytoplasmic binding partner of the membrane form of heparin-binding EGF-like growth factor: A unique role for proHB-EGF in cell survival regulation. J Biol Chem. 2001; 276: 30127–32
- Luders J, Pyrowolakis G, Jentsch S. The ubiquitin-like protein HUB1 forms SDS-resistant complexes with cellular proteins in the absence of ATP. EMBO Rep. 2003; 4: 1169–74
- Sharp A, Crabb SJ, Cutress RI, Brimmell M, Wang XH, Packham G, et al. BAG-1 in carcinogenesis. Expert Rev Mol Med. 2004; 2004: 1–15
- Cutress RI, Townsend PA, Sharp A, Maison A, Wood L, Lee R, et al. The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription. Oncogene. 2003; 22: 4973–82
- Brimmell M, Burns JS, Munson P, McDonald L, O'Hare MJ, Lakhani SR, et al. High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers. Br J Cancer. 1999; 81: 1042–51
- Tang SC, Shehata N, Chernenko G, Khalifa M, Wang X. Expression of BAG-1 in invasive breast carcinomas. J Clin Oncol. 1999; 17: 1710–9
- Townsend PA, Dublin E, Hart IR, Kao RH, Hanby AM, Cutress RI, et al. BAG-i expression in human breast cancer: Interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data. J Pathol. 2002; 197: 51–9
- Turner BC, Krajewski S, Krajewska M, Takayama S, Gumbs AA, Carter D, et al. BAG-1: A novel biomarker predicting long-term survival in early-stage breast cancer. J Clin Oncol. 2001; 19: 992–1000
- Moriyama T, Littell RD, Debernardo R, Oliva E, Lynch MP, Rueda BR, et al. BAG-1 expression in normal and neoplastic endometrium. Gynecol Oncol. 2004; 94: 289–95
- Erkanli S, Eren F, Pekin S, Bagis T. BCL-2 and P53 expression in endometrial carcinoma. J Exp Clin Cancer Res. 2004; 23: 97–103
- Vaskivuo TE, Stenback F, Tapanainen JS. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma. Cancer. 2002; 95: 1463–71
- Roth W, Grimmel C, Rieger L, Strik H, Takayama S, Krajewski S, et al. Bag-1 and Bcl-2 gene transfer in malignant glioma: Modulation of cell cycle regulation and apoptosis. Brain Pathol. 2000; 10: 223–34